We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Karolinska Development Ab | LSE:0P3C | London | Ordinary Share | SE0002190926 | KAROLINSKA DEVELOPMENT B ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 6.50 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 1.84M | -8.1M | -0.0303 | -214.52 | 1.74B |
| Date | Time | Source | Headline |
|---|---|---|---|
| 18/3/2025 | 14:00 | UKREG | Karolinska Development’s portfolio company Umecrine Cognition provides.. |
| 13/3/2025 | 08:30 | UKREG | Karolinska Development’s portfolio company AnaCardio has been granted.. |
| 12/3/2025 | 14:23 | UKREG | Karolinska Development's portfolio company PharmNovo receives positive FDA.. |
| 25/2/2025 | 08:10 | UKREG | Karolinska Development’s portfolio company AnaCardio includes first patient.. |
| 18/2/2025 | 13:17 | UKREG | Karolinska Developments portfolio company Promimic publishes positive.. |
| 14/2/2025 | 07:00 | UKREG | Year-end Report - January-December 2024 |
| 30/1/2025 | 07:50 | UKREG | Karolinska Development’s portfolio company Dilafor advances tafoxiparin.. |
| 09/1/2025 | 10:50 | UKREG | Karolinska Development’s portfolio company AnaCardio raises SEK 205 million.. |
| 19/12/2024 | 07:50 | UKREG | Karolinska Development’s portfolio company Umecrine Cognition raises MSEK.. |
| 18/12/2024 | 15:30 | UKREG | Karolinska Development’s Board of Directors appoints Ben Toogood as new.. |
1 Year Karolinska Development Ab Chart |
Intraday Karolinska Development Ab Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
